Ally Bridge Group

Founded in 2013 by Frank Yu, Ally Bridge Group is a specialized global life science investment firm with dual headquarters in Hong Kong and New York. The firm is dedicated to investing in cutting-edge life science innovations, from private to public companies, across various stages of development. Ally Bridge Group leverages its deep industry expertise and global network to support its portfolio companies in the U.S., China, and Europe, focusing on areas like biotech, medtech, and healthcare services.